| Critical care services and 2009 H1N1 influenza in Australia and New Zealand ANZIC Influenza Investigators New England Journal of Medicine 361 (20), 1925-1934, 2009 | 1469 | 2009 |
| Interleukin-6 receptor antagonists in critically ill patients with Covid-19–preliminary report Remap-Cap Investigators, AC Gordon, PR Mouncey, F Al-Beidh, ... Medrxiv, 2021.01. 07.21249390, 2021 | 1340 | 2021 |
| Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial DC Angus, L Derde, F Al-Beidh, D Annane, Y Arabi, A Beane, ... Jama 324 (13), 1317-1329, 2020 | 835 | 2020 |
| Restrictive versus liberal fluid therapy for major abdominal surgery PS Myles, R Bellomo, T Corcoran, A Forbes, P Peyton, D Story, ... New England Journal of Medicine 378 (24), 2263-2274, 2018 | 661 | 2018 |
| Fluid challenges in intensive care: the FENICE study: a global inception cohort study M Cecconi, C Hofer, JL Teboul, V Pettila, E Wilkman, Z Molnar, ... Intensive care medicine 41, 1529-1537, 2015 | 626 | 2015 |
| Interleukin-6 receptor antagonists in critically ill patients with Covid-19 Remap-Cap Investigators New England Journal of Medicine 384 (16), 1491-1502, 2021 | 613 | 2021 |
| Nasal high-flow therapy delivers low level positive airway pressure R Parke, S McGuinness, M Eccleston British journal of anaesthesia 103 (6), 886-890, 2009 | 559 | 2009 |
| Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis P Domingo, I Mur, GM Mateo, M del Mar Gutierrez, V Pomar, N de Benito, ... Jama 326 (6), 499-518, 2021 | 477 | 2021 |
| The effects of flow on airway pressure during nasal high-flow oxygen therapy RL Parke, ML Eccleston, SP McGuinness Respiratory care 56 (8), 1151-1155, 2011 | 417 | 2011 |
| Pressures delivered by nasal high flow oxygen during all phases of the respiratory cycle RL Parke, SP McGuinness Respiratory care 58 (10), 1621-1624, 2013 | 339 | 2013 |
| The REMAP-CAP (randomized embedded multifactorial adaptive platform for community-acquired pneumonia) study. Rationale and design DC Angus, S Berry, RJ Lewis, F Al-Beidh, Y Arabi, W van Bentum-Puijk, ... Annals of the American Thoracic Society 17 (7), 879-891, 2020 | 313 | 2020 |
| A preliminary randomized controlled trial to assess effectiveness of nasal high-flow oxygen in intensive care patients RL Parke, SP McGuinness, ML Eccleston Respiratory Care 56 (3), 265-270, 2011 | 264 | 2011 |
| A binational multicenter pilot feasibility randomized controlled trial of early goal-directed mobilization in the ICU CL Hodgson, M Bailey, R Bellomo, S Berney, H Buhr, L Denehy, B Gabbe, ... Critical care medicine 44 (6), 1145-1152, 2016 | 227 | 2016 |
| Intravenous vitamin C in adults with sepsis in the intensive care unit F Lamontagne, MH Masse, J Menard, S Sprague, R Pinto, DK Heyland, ... New England Journal of Medicine 386 (25), 2387-2398, 2022 | 198 | 2022 |
| Open-label, phase II study of routine high-flow nasal oxygen therapy in cardiac surgical patients R Parke, S McGuinness, R Dixon, A Jull British journal of anaesthesia 111 (6), 925-931, 2013 | 197 | 2013 |
| Effect of convalescent plasma on organ support–free days in critically ill patients with COVID-19: a randomized clinical trial H Abdelhady, M Abdelrazik, Z Abdi, D Abdo, A Abdulle, L Abel, ... Jama 326 (17), 1690-1702, 2021 | 193 | 2021 |
| Effect of very-high-flow nasal therapy on airway pressure and end-expiratory lung impedance in healthy volunteers RL Parke, A Bloch, SP McGuinness Respiratory care 60 (10), 1397-1403, 2015 | 190 | 2015 |
| Goal-directed perfusion to reduce acute kidney injury: a randomized trial M Ranucci, I Johnson, T Willcox, RA Baker, C Boer, A Baumann, ... The Journal of thoracic and cardiovascular surgery 156 (5), 1918-1927. e2, 2018 | 185 | 2018 |
| Australian and New Zealand college of anaesthetists clinical trials network and the Australian and New Zealand Intensive Care Society Clinical Trials Group. Restrictive versus … PS Myles, R Bellomo, T Corcoran, A Forbes, P Peyton, D Story, ... N Engl J Med 378 (24), 2263-2274, 2018 | 158 | 2018 |
| Targeted therapeutic mild hypercapnia after cardiac arrest: a phase II multi-centre randomised controlled trial (the CCC trial) GM Eastwood, AG Schneider, S Suzuki, L Peck, H Young, A Tanaka, ... Resuscitation 104, 83-90, 2016 | 157 | 2016 |
